2.8400
+0.2900
+(11.37%)
At close: April 17 at 4:00:00 PM EDT
2.7100
-0.13
(-4.58%)
After hours: April 17 at 7:06:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-14,367
-14,367
-19,925
-16,735
-15,251
Investing Cash Flow
509
509
13,881
19,914
13,406
Financing Cash Flow
6,774
6,774
5,449
1,114
1,512
Cash Flow from Discontinued Operation
--
--
--
--
-374
End Cash Position
7,401
7,401
14,489
15,030
10,890
Capital Expenditure
--
--
-3
-228
-115
Issuance of Capital Stock
5,809
5,809
1,563
1,498
564
Repayment of Debt
-183
-183
-168
-165
-153
Free Cash Flow
-14,367
-14,367
-19,928
-16,963
-15,366
12/31/2021 - 11/20/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNTI Senti Biosciences, Inc.
3.8800
+4.02%
CANF Can-Fite BioPharma Ltd.
1.2000
-2.44%
GNTA Genenta Science S.p.A.
3.8800
+4.30%
BLRX BioLineRx Ltd.
2.8800
+3.97%
RNTX Rein Therapeutics Inc.
1.7000
+3.03%
SLGL Sol-Gel Technologies Ltd.
0.5500
+7.84%
AIMI AIM ImmunoTech Inc.
0.0400
+14.29%
ENTX Entera Bio Ltd.
1.7900
+1.70%
VERA Vera Therapeutics, Inc.
21.29
+0.24%
ORMP Oramed Pharmaceuticals Inc.
2.1500
-2.27%